drugset / Trial / NCT01949935
Efficacy Study of Mupirocin on Infection After Coronary Artery Bypass Grafting
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The hypothesis is that application of Mupirocin to the nose before and after coronary artery bypass grafting surgery will reduce the incidence of surgical site infections.
Timeline
- Start
- 2009-03
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mupirocin | Small molecule | — | Intranasal |
Indications
No indication recorded.